Question 1

Am I eligible for this expanded access program?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Karyopharm Expanded Access Program for Selinexor clinical trial (NCT07215832). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential benefits and risks of using selinexor?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Karyopharm Expanded Access Program for Selinexor clinical trial (NCT07215832). Contact the study team or your healthcare provider for specific answers.

Question 3

How does selinexor compare to other treatments I have already tried?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Karyopharm Expanded Access Program for Selinexor clinical trial (NCT07215832). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the logistics of obtaining selinexor through this program?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Karyopharm Expanded Access Program for Selinexor clinical trial (NCT07215832). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my treatment be monitored while using selinexor?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Karyopharm Expanded Access Program for Selinexor clinical trial (NCT07215832). Contact the study team or your healthcare provider for specific answers.

Question 6

What should I do if I experience side effects from the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Karyopharm Expanded Access Program for Selinexor clinical trial (NCT07215832). Contact the study team or your healthcare provider for specific answers.

What this study is about